Partner Interview
Published July 29, 2025
Sartorius: Legacy Precision Meets Commercial Friction
inpractise.com/articles/sartorius-legacy-precision-meets-commercial-friction
Executive Bio
Former VP at Sartorius
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
What were some concrete ways you tried to change the way Sartorius worked?
The first thing we needed was to move to dynamic pricing. In 2020 and 2021, it was impossible to maintain a fixed price for the entire year due to supply chain disruptions and fluctuating production costs. We needed to respond to market conditions because, for instance, we forecasted a 5% increase in production costs, but it turned out to be 12% higher for some products and 3% lower for others. Having the flexibility to make pricing changes was crucial. Secondly, we needed to stop pricing products that hadn't sold in a while and clear out old inventory. Some products were outdated, and only 1% of our customer base was using a bag that was three generations old. Upgrading customers to newer products not only increased the price and yield but also simplified our product offerings. This reduced confusion and questions about outdated products. The opportunity was twofold in terms of where we were in that pricing journey.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content

Thermo Fisher Scientific Inc: Culture and Management
Former Director at Thermo Fisher Scientific

Danaher, Aldevron, Intangible & Goodwill Impairments

Porvair & Chromatography Lab Equipment: M&A Process & Culture
Former Senior Vice President Life Sciences at J.G. Finneran, Porvair plc

Thermo Fisher vs Danaher: Business Model and Competitive Positioning
Former Director, Corporate Strategy & Business Development at Thermo Fisher Scientific
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.